Cidara Therapeutics, Inc. (CDTX)
NASDAQ: CDTX · Real-Time Price · USD
62.90
-0.41 (-0.65%)
At close: Aug 1, 2025, 4:00 PM
60.01
-2.89 (-4.59%)
After-hours: Aug 1, 2025, 6:13 PM EDT

Company Description

Cidara Therapeutics, Inc. operates as a biotechnology company that focuses on developing targeted therapies for patients facing cancers and other serious diseases.

The company’s product includes rezafungin acetate, a novel molecule in the echinocandin class of antifungals for the treatment and prevention of invasive fungal infections, including candidemia and invasive candidiasis, which are fungal infections associated with high mortality rates.

It also develops its Cloudbreak platform that enables development of novel drug-Fc conjugates, that includes CD388, a potent antiviral designed to deliver universal prevention and treatment of seasonal and pandemic influenza, which is in Phase 1 and Phase 2a clinical trials.

The company was formerly known as K2 Therapeutics, Inc. and changed its name to Cidara Therapeutics, Inc. in July 2014.

Cidara Therapeutics, Inc. was incorporated in 2012 and is based in San Diego, California.

Cidara Therapeutics, Inc.
Cidara Therapeutics logo
CountryUnited States
Founded2012
IPO DateApr 15, 2015
IndustryBiotechnology
SectorHealthcare
Employees38
CEOJeffrey Stein

Contact Details

Address:
6310 Nancy Ridge Drive, Suite 101
San Diego, California 92121
United States
Phone(858) 752-6170
Websitecidara.com

Stock Details

Ticker SymbolCDTX
ExchangeNASDAQ
Fiscal YearJanuary - December
Reporting CurrencyUSD
CIK Code0001610618
CUSIP Number171757206
ISIN NumberUS1717572069
Employer ID46-1537286
SIC Code2836

Key Executives

NamePosition
Dr. Jeffrey L. Stein Ph.D.President, Chief Executive Officer and Executive Director
Dr. Leslie Tari Ph.D.Chief Scientific Officer
Dr. Kevin M. Forrest Ph.D.Founder and Chief Strategy Officer
Frank L. Karbe M.B.A.Chief Financial Officer
Shane M. Ward J.D.Chief Operating Officer and Corporate Secretary
Dr. Preetam Shah M.B.A., Ph.D.Principal Accounting Officer
Allison Lewis CCP, SPHRSenior Vice President of People and Culture
Dr. Nicole Davarpanah J.D., M.D.Chief Medical Officer
Jim Beitel M.B.A.Chief Business Officer
Corrina PavettoSenior Vice President of Clinical Development

Latest SEC Filings

DateTypeTitle
Jul 30, 2025SCHEDULE 13GFiling
Jul 17, 2025SCHEDULE 13GFiling
Jul 2, 2025SCHEDULE 13GFiling
Jun 30, 2025SCHEDULE 13D/AFiling
Jun 25, 20258-KCurrent Report
Jun 25, 2025424B5Filing
Jun 24, 20258-KCurrent Report
Jun 23, 2025424B5Filing
Jun 23, 20258-KCurrent Report
Jun 20, 20258-KCurrent Report